about
Molecular Pathogenesis of NASHChallenges of advanced hepatocellular carcinomaInterferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadc-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cellsPhosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cellsGenome-wide meta-analyses identify three loci associated with primary biliary cirrhosisManagement strategies for hepatocellular carcinoma: old certainties and new realities.Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cellsCurcumin limits the fibrogenic evolution of experimental steatohepatitis.Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study.Therapeutic application of stem cells in gastroenterology: an up-date.Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cellsThiazolidinediones and hepatic fibrosis: don't wait too long.Renaming cytokines: MCP-1, major chemokine in pancreatitisLeptin and liver tissue repair: do rodent models provide the answers?Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.Pathophysiology of NASH: perspectives for a targeted treatment.Role of adipocytokines in hepatic fibrosis.Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.Adipokines and redox signaling: impact on fatty liver disease.Fibrosis in alcoholic and nonalcoholic steatohepatitis.Modulation of liver fibrosis by adipokines.Transient Hepatic Parenchymal Enhancement detected at dynamic imaging: a short instruction manual for the clinician.The metabolic syndrome and chronic liver disease.Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.Roles for chemokines in liver disease.A nuclear protein in mesangial cells that binds to the promoter region of the platelet-derived growth factor-A chain gene. Induction by phorbol ester.Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.Hepatic brucellar abscess.gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis.Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis.The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.Screening of distress among hospitalized patients in a department of internal medicine.
P50
Q28071265-EDAFD207-B522-4E77-9628-08C5AC0B7B0AQ28076867-EAE74253-49D5-41B9-A122-40E8F7250AD9Q28142692-EE62144C-4123-49B1-A30F-00CF778FF6C9Q28252598-9DB4646E-8AE5-4FD2-B51B-7A1DF2AE26A2Q28372756-09D371D6-7F71-4273-8FCA-3496C4B1DA02Q28943317-3B730F5F-E6C1-4801-8DE5-66A06B78E644Q30252143-0C370E99-60B8-435F-B2DC-F8E4EAE76676Q32076074-8A3808A8-F7ED-4B1D-9BB9-D0150940633CQ33904041-3FDA5C45-59FC-4F43-BD34-348AC179AA6EQ34078634-0A98971B-E993-4D5E-84DF-CF2019720E9CQ34613675-D25ED887-0A0C-4D87-9F59-A1F56808DFB4Q35169370-1475BF2C-5BCF-4B63-8B37-E70568244EC9Q35404189-80DC9334-9D51-4046-961D-86E29C48A98DQ35569812-38F940BD-D60D-4C85-BCD3-00C3CB2D7DF6Q35760700-3F4A69C5-45BD-4230-965F-AB7E4E0D4ED3Q36164454-7B0767BC-D08A-432C-B2BE-B96CA4404882Q36656657-BE140609-F889-4C38-B759-AC1BB85E98CDQ37006004-C30F60FD-5545-4B47-A167-6FEC72BE3A11Q37064636-6C850138-76D4-4D5D-9664-CF8BE07072DBQ37078109-FD5A1F8C-0F25-4236-A0AE-976614FE7282Q37359399-C9D2390E-3D39-419D-9468-B8600FF79966Q37490603-BEDC8C89-4893-4B1C-8816-D6FF04190347Q37578600-35FB0F24-77C8-4543-B7BE-7D538C85A696Q37699476-B4C2DF5E-D792-4C83-AFF1-C6AEEA9A6980Q37725009-940F919F-3C99-4B1E-A336-E300A6B0D808Q37749356-81B97140-6660-4308-9167-AC37D3097D38Q37824870-68235548-8B59-42C5-98C6-A11DF18DDB3DQ37865863-A241ADF0-E3F3-4E36-8344-3D51146BF5A0Q37926851-875D0C6E-C7C2-4AF6-8133-16504C81BB8BQ37966280-077A70C5-F73C-42CF-A975-16E6A06C7B13Q38169739-CA196DEB-05CB-4AB0-99A6-AC9BA1FEE7DEQ38191599-79535F82-1581-429E-BA2A-1C7F19B032E6Q38234487-852FAC1C-9E9E-4AE9-9C4A-21165C4F2C9BQ38297740-57E7A943-5183-4130-9453-0CEEF841EAA5Q38655966-E5FABB7D-7CE1-47A8-B56C-83F64788591AQ38895011-5254D836-C703-4955-B769-2A7A7265EAF7Q38924171-565AB7BF-AC3E-48C4-91F4-9B09D02593E7Q38989240-F38149EA-F4CE-49DC-A06B-750DF21485C1Q39028881-44469804-C9F6-452A-A200-CEEA934779A6Q39195514-F701EF72-6B5A-485B-8E0A-DA1296937CBA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabio Marra
@ast
Fabio Marra
@en
Fabio Marra
@es
Fabio Marra
@nl
Fabio Marra
@sl
type
label
Fabio Marra
@ast
Fabio Marra
@en
Fabio Marra
@es
Fabio Marra
@nl
Fabio Marra
@sl
prefLabel
Fabio Marra
@ast
Fabio Marra
@en
Fabio Marra
@es
Fabio Marra
@nl
Fabio Marra
@sl
P1053
K-7263-2016
P106
P1153
34570669100
P21
P31
P3829
P496
0000-0001-8629-0878